Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study

被引:3
|
作者
Hegedus, Katalin [1 ]
Karpati, Judit [1 ]
Iljicsov, Anna [1 ]
Simo, Magdolna [1 ]
机构
[1] Semmelweis Univ, Dept Neurol, Balassa J U 6, H-1083 Budapest, Hungary
关键词
Multiple sclerosis; Benign; Cognitive impairment; Disease modifying treatment; Depression; STOP FOOLING OURSELVES; COGNITIVE IMPAIRMENT; DEPRESSION; SYMPTOMS; ANXIETY; RARE; MS;
D O I
10.1016/j.msard.2019.07.022
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The definition of benign multiple sclerosis (BMS) is still debated. It is mainly based on physical status, however, there is an attempt to involve cognitive functioning or paraclinical factors in order to avoid unnecessary long-term treatment with disease-modifying therapies and to identify these subjects in the early stages of the disease. Therefore the aim of our two-year follow-up study was to investigate the pattern of cognitive functioning and depression in patients with BMS compared to treated relapsing-remitting MS (RRMS) patients and healthy controls. Methods: A group of 22 BMS patients was tested against matched RRMS patients and healthy controls. All individuals underwent neuropsychological evaluation exploring mood and the cognitive domains most frequently impaired in MS. MS patients were retested at two-year follow-up. Results: In terms of cognitive functions there were no differences between BMS and RRMS patients either at baseline or at two-year follow-up. Compared to healthy controls BMS patients showed poorer performance in long-term visuo-spatial memory and information processing speed, whereas, complex attention, working memory, long-term verbal memory - despite slower verbal learning - and executive function were found to be intact. RRMS patients showed significant difference in complex attention, long-term visual memory and information processing speed. Cognitive impairment differed in the patient groups in terms of severity. Both patient groups were depressed compared to controls, but significant differences were found only between BMS and healthy individuals. Conclusion: The results of our study confirm that cognitive functions and mood can be affected in MS independent of disease course and disease modifying treatment. The "benign" label should be treated as only a reference to physical status and non-motor symptoms should be routinely monitored. Without receiving therapy it is an existing entity with longstanding minimal disability.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 50 条
  • [31] Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis
    Laule, C.
    Vavasour, I. M.
    Zhao, Y.
    Traboulsee, A. L.
    Oger, J.
    Vavasour, J. D.
    Mackay, A. L.
    Li, D. K. B.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (06) : 670 - 677
  • [32] Vitamin D supplementation in Multiple Sclerosis: time matters. A two-year observational study
    Ragonese, P.
    Realmuto, S.
    Bianchi, A.
    Portera, E.
    Alessi, S.
    Scazzone, C.
    Ciaccio, M.
    Vazzoler, G.
    Savettieri, G.
    Salemi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 544 - 544
  • [33] Breast Cancer Survival in Multiple Sclerosis A Matched Cohort Study
    Marrie, Ruth Ann
    Maxwell, Colleen
    Mahar, Alyson
    Ekuma, Okechukwu
    McClintock, Chad
    Seitz, Dallas
    Groome, Patti
    NEUROLOGY, 2021, 97 (01) : E13 - E22
  • [34] Is benign multiple sclerosis truly benign? A socioeconomic investigative nationwide cohort study
    Wandall-Holm, M. F.
    Buron, M. D.
    Holm, R. P.
    Sellebjerg, F.
    Magyari, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 459 - 460
  • [35] Donation After Circulatory Death: Two-Year Outcomes in a Propensity-Matched Cohort
    Silver, E.
    Reddy, N.
    Rubarth, R. Barriola
    Lin, A.
    Pretorius, V.
    Urey, M.
    Kearns, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S265 - S266
  • [36] Treatment effects in multiple cognitive domains in Alzheimer’s disease: a two-year cohort study
    Pearl Behl
    Jodi D Edwards
    Alexander Kiss
    Krista L Lanctot
    David L Streiner
    Sandra E Black
    Donald T Stuss
    Alzheimer's Research & Therapy, 6
  • [37] Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study
    Behl, Pearl
    Edwards, Jodi D.
    Kiss, Alexander
    Lanctot, Krista L.
    Streiner, David L.
    Black, Sandra E.
    Stuss, Donald T.
    ALZHEIMERS RESEARCH & THERAPY, 2014, 6 (04):
  • [38] A 20-year follow-up study of benign multiple sclerosis in Western Australian cohort
    Fabis-Pedrini, Marzena J.
    Seewann, Alexandra
    Yau, Wai Yan
    van de Bovenkamp, Arno
    James, Ian
    Burton, Jason
    Carroll, William
    Kermode, Allan
    NEUROLOGY, 2017, 88
  • [39] Evaluation of Efficacy and Safety After Switching to Generic Fingolimod in Patients with Multiple Sclerosis: A Two-Year Follow-Up Study
    Moreno Torres, Irene
    Orviz, Aida
    Nystrom Hernandez, Anna Lena
    De la Fuente, Soraya
    Arrieta Loitegui, Maria
    Hernandez Segurado, Marta
    Becares Martinez, Javier
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1083 - 1083
  • [40] Two-year follow-up of regulatory B cells following alemtuzumab in multiple sclerosis patients
    Kim, Y.
    Kim, G.
    Shin, H. -J.
    Hyun, J. -W.
    Kim, S. -H.
    Kim, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 464 - 464